Compare Adobe Systems Inc (ADBE) vs Pfizer Inc (PFE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adobe Systems Inc vs Pfizer Inc — how do they compare? Adobe Systems Inc trades at $221.06 (market cap $88.06B), while Pfizer Inc trades at $24.11 (market cap $137.19B). The key difference: Pfizer Inc is the larger of the two by market cap, and Pfizer Inc pays a 7.15% dividend while Adobe Systems Inc pays none. Which is the better fit depends on your goals.
| ADBE | PFE | |
|---|---|---|
Market Cap | $88.06B | $137.19B |
Volume | 5,187,646 | 29,869,932 |
Sector | Technology | Health |
52-Week High | $382.24 | $28.56 |
52-Week Low | $193.41 | $23.29 |
Enterprise Value | $89.50B | $187.84B |
Dividend Yield | — | 7.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Adobe Inc. (ADBE) trades at $220.92, up 1.31% with a bullish technical signal despite recent volatility. The company shows strong fundamentals with Q1 2026 EPS beating expectations at $5.96 versus $5.82, revenue growth to $23.77B in 2025, and robust profitability margins. However, negative net cash flow of -$2.18B in 2025 and AI competition concerns from recent news create mixed sentiment.
Outlook remains positive with a consensus price target of $246.75, representing 11.7% upside, supported by 49.21% analyst buy ratings. Key risks include AI disruption fears and CEO transition uncertainty, but Adobe's entrenched market position and double-digit growth provide a solid foundation for long-term investors.
Pfizer (PFE) trades at $23.72, down 2.47% on the day, with a bearish technical signal from moving averages but recent earnings beats. The stock has a P/E of 18.11 and net income margin of 11.83%, supported by strong cash flow from operations of $11.70B in 2025. Recent news highlights pipeline progress in obesity and oncology, with dividends of $0.43 paid semi-annually.
The outlook is mixed: analyst consensus is a 'Hold' with a $27.63 price target, implying potential upside, but risks include patent cliffs and competitive pressures. Revenue has declined from pandemic peaks, yet cost controls sustain profitability. Investors may find value if pipeline catalysts materialize, though near-term volatility persists.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adobe Systems Inc
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
